Sun Pharma share price

Sun Pharmaceuticals share price fell 2% to hit an intraday low of Rs 856.7 on NSE on Tuesday after the drug maker reported a surprise net loss of Rs 2,227.38 crore for the quarter ended March 2022. Company’s revenue for the quarter rose 11% from a year ago to Rs 9,386.08 crore. The firm also reappointed Dilip Shanghvi as a managing director for a further term of five years and Pawan Goenka was appointed lead independent director. So far this year.

Sun Pharma share price falls 2% after Q4 results fail to beat estimates; brokerages see up to 22% upside

Sun Pharma share price under pressure after surprise Q4 loss but CLSA expects 22% upside.

Sun Pharma Q4 Results: Firm posts surprise loss of Rs 2,277 crore

Sun Pharma share price: Why did stocks of India’s top pharmaceutical firm fall?

Q4 Results 2022: Sun Pharma, Natco Pharma, Omaxe declare March quarter results; key highlights here


Leave a Reply

Your email address will not be published. Required fields are marked *